Yousif Capital Management LLC Trims Position in Select Medical Holdings Corporation (NYSE:SEM)

Yousif Capital Management LLC decreased its position in shares of Select Medical Holdings Corporation (NYSE:SEM) by 3.2% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 39,264 shares of the health services provider’s stock after selling 1,300 shares during the quarter. Yousif Capital Management LLC’s holdings in Select Medical were worth $656,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Smartleaf Asset Management LLC grew its position in Select Medical by 179.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider’s stock worth $43,000 after acquiring an additional 1,473 shares in the last quarter. Covestor Ltd lifted its stake in shares of Select Medical by 33.5% in the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider’s stock valued at $93,000 after purchasing an additional 1,244 shares during the last quarter. Lazard Asset Management LLC lifted its stake in shares of Select Medical by 47.8% in the 4th quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider’s stock valued at $130,000 after purchasing an additional 2,255 shares during the last quarter. Quarry LP boosted its holdings in shares of Select Medical by 963.0% in the 4th quarter. Quarry LP now owns 9,078 shares of the health services provider’s stock worth $171,000 after purchasing an additional 8,224 shares during the period. Finally, HBK Investments L P bought a new position in shares of Select Medical during the 4th quarter valued at approximately $188,000. Institutional investors own 89.48% of the company’s stock.

Insider Buying and Selling

In related news, CEO David S. Chernow sold 225,000 shares of the stock in a transaction on Monday, April 28th. The shares were sold at an average price of $18.00, for a total value of $4,050,000.00. Following the transaction, the chief executive officer now directly owns 714,516 shares of the company’s stock, valued at $12,861,288. This trade represents a 23.95% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Parvinderjit S. Khanuja purchased 21,000 shares of the firm’s stock in a transaction that occurred on Monday, May 5th. The shares were acquired at an average price of $15.02 per share, with a total value of $315,420.00. Following the purchase, the director now owns 65,089 shares in the company, valued at $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. 11.60% of the stock is owned by insiders.

Select Medical Trading Down 0.6%

Shares of SEM stock opened at $14.83 on Friday. Select Medical Holdings Corporation has a fifty-two week low of $14.03 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.16 and a current ratio of 1.16. The stock’s fifty day moving average is $15.56 and its two-hundred day moving average is $17.44. The firm has a market capitalization of $1.91 billion, a P/E ratio of 11.06, a PEG ratio of 0.79 and a beta of 1.34.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.01). Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.40 billion. During the same period in the prior year, the company posted $0.75 EPS. The company’s revenue for the quarter was down 24.4% compared to the same quarter last year. Research analysts expect that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical declared that its board has authorized a stock repurchase plan on Thursday, May 1st that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to purchase up to 42.6% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a $0.0625 dividend. The ex-dividend date was Thursday, May 15th. This represents a $0.25 annualized dividend and a yield of 1.69%. Select Medical’s dividend payout ratio (DPR) is 18.66%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Wall Street Zen upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Royal Bank Of Canada dropped their price objective on Select Medical from $23.00 to $19.00 and set an “outperform” rating for the company in a report on Wednesday, May 7th. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research note on Monday, February 24th. Finally, Mizuho started coverage on Select Medical in a research report on Wednesday, April 16th. They set an “outperform” rating and a $25.00 target price for the company. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Select Medical has an average rating of “Moderate Buy” and a consensus price target of $26.00.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.